Login
Login
切换导航
Home
Articles
Journals
Books
News
About
Services
Submit
Home
Journal
Citations
Journals Menu
Articles
Archive
Indexing
Aims & Scope
Editorial Board
For Authors
Publication Fees
Open Special Issues
Published Special Issues
Special Issues Guideline
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Journal of Cancer Therapy
Submission
Journal of Cancer Therapy
ISSN Print:
2151-1934
ISSN Online:
2151-1942
www.scirp.org/journal/jct
E-mail:
jct@scirp.org
Citations
h5
-index & Ranking
Journals Menu
Articles
Archive
Indexing
Aims & Scope
Editorial Board
For Authors
Publication Fees
"
Nimotuzumab with Concurrent Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN)
"
written by
Naresh Somani
,
published by
Journal of Cancer Therapy
,
Vol.6 No.4, 2015
has been cited by the following article(s):
Google Scholar
CrossRef
[1]
Nimotuzumab combined with radiotherapy for the treatment of hypopharyngeal cancer-A case report from a tertiary cancer center
2021
[2]
Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck …
2019
[3]
Retracted: Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway
2019
[4]
Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural …
2019
[5]
Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An …
2019
[6]
Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway
2019
[7]
Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and …
2019
[8]
Joint Editors: Dr. Kumar Prabhash
2019
[9]
Nimotuzumab with concurrent chemoradiation in inoperable locally advanced squamous cell carcinoma of head and neck: An Indian experience
2018
[10]
Monoclonal antibody‐based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
Journal of Pharmacy and Pharmacology
,
2018
[11]
Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based …
2018
[12]
Clinical immunotherapeutic approaches for the treatment of head and neck cancer
International Journal of Oral and Maxillofacial Surgery
,
2018
[13]
Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
2018
[14]
Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: a hospital-based retrospective …
2018
[15]
Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer
2017
[16]
Oncology gold standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of …
2017
[17]
Oncology gold standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and …
2017
[1]
Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
Journal of Pharmacy and Pharmacology
,
2018
DOI:
10.1111/jphp.12911
[2]
Clinical immunotherapeutic approaches for the treatment of head and neck cancer
International Journal of Oral and Maxillofacial Surgery
,
2018
DOI:
10.1016/j.ijom.2018.10.012
Most cited
Most downloaded
E-Mail Alert
JCT Subscription
Publication Ethics & OA Statement
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact us
Disclaimer
History Issue
Open Special Issues
Published Special Issues
Special Issues Guideline
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Home
Journals A-Z
Subject
Books
Sitemap
Contact Us
About SCIRP
Publication Fees
For Authors
Peer-Review Issues
Special Issues
News
Service
Manuscript Tracking System
Subscription
Translation & Proofreading
FAQ
Volume & Issue
Policies
Open Access
Publication Ethics
Preservation
Retraction
Privacy Policy
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top